Delivery Order SPE2DR25D2104-SPE2DR26F3RSQ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,299.74 for Rexulti 2 mg tablets (30-count) with a firm fixed price structure. The award, made on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a non-competitive delivery order under the company's larger prime contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rexulti 1 mg tablets (30-count) at a ceiling value of $5,400.39. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is scheduled for ultimate completion on November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 13, 2025, with a ceiling value of $1,002.23 and firm fixed pricing. This delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor, with an ultimate completion date of August 14, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,662.12 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count units) under a firm fixed-price contract. The award was made on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Rexulti 2 mg tablets (30-count packages) with a ceiling value of $9,967.07. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $3,450.58 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count package), with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single pharmaceutical product delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $18,081.18, for 30-count tablets of Rexulti 1 mg on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Rexulti 0.5 mg tablets (30-count) with a ceiling value of $9,382.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 1, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's ability to compete in open federal...
- The Defense Logistics Agency awarded a $39,573.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (quantity 30) on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3RSQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,890.22 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price, non-competitive delivery order represents a continuation of AmerisourceBergen's extensive role as a pharmaceutical supplier to the federal government. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement that extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Through this prime vendor arrangement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning the company as a critical pharmaceutical logistics provider for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/16/25 |